Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Paclitaxel Shortage May Add Millions to Cost of Ovarian Cancer Care

June 27th 2012

A chronic shortage of the most commonly used taxane for ovarian cancer would add almost $9 million a month to the cost of care if half of newly diagnosed cases were affected.

Urology Under Attack

June 21st 2012

As we head into the sweltering days of summer, physicians-and urologists in particular-face a series of challenges that can potentially impact the way we practice and how we manage our patients.

Dr. Schilsky Summarizes the Oncology Drug Shortage

June 21st 2012

Dr. Richard Schilsky, from the University of Chicago, Summarizes the Recent Oncology Drug Shortage.

Health Insurance Gaps

June 20th 2012

2011 survey finds 25% of adults experienced a gap in health insurance last year.

Dr. Ryan Discusses Sequencing Prostate Cancer Therapies

June 18th 2012

Dr. Charles Ryan, from UCSF Helen Diller Family Comprehensive Cancer Center, Discusses Sequencing Castration-Resistant Prostate Cancer Therapies.

The Changing World of Oncology Practice

June 18th 2012

Economic pressures are forcing many oncologists to leave small private practices for larger institutional organizations.

There and Back…

June 15th 2012

One of my teachers in medical school was fond of saying, "Internal medicine isn't sexy." Hematology/ oncology is no exception to this rule. Certainly, it is not as glamorous as cardiology or as hands-on as gastroenterology.

Finding Time: A Day in the Life of an Academic Oncologist

June 15th 2012

We all have to balance competing demands on our time. But as an academic oncologist, I have to keep a foot in 2 worlds, research and clinical, while still keeping my balance.

From a Distance: Managing Side Effects in Outpatients

June 12th 2012

Checking in with patients can bring positive results, since oncology nurses are able to offer interventions for most symptoms of cancer treatment. Includes an in-depth look at telephone triage.

IPCC Case-Based Discussion: How Should We Sequence Therapy?

June 12th 2012

Three case studies focused on how best to sequence therapy in prostate cancer were presented by Daniel P. Petrylak, MD, and discussed by a panel that included Robert Dreicer, MD, and Oliver Sartor, MD.

Unraveling the Complexity of Drug Shortages: Grim Reality Is a Bitter Pill to Swallow

June 7th 2012

An interview with ASCO President Michael P. Link, MD, discussing the impact of oncology drug shortages.

FDA and Industry Collaborating to Prevent Cancer Drug Shortages

June 5th 2012

Drug manufacturers are working with the FDA to report anticipated shortages earlier and ensure alternative sources of needed drugs are available.

Dr. Gomella on the Impact of the New USPSTF PSA Rating

May 22nd 2012

Dr. Leonard Gomella, form the Jefferson Kimmel Cancer Center, on the Impact of the New USPSTF PSA Rating.

Bending the Cost Curve and Here Come the Judge(s)

May 17th 2012

Lately, business and government have done more to "move the needle" in changing healthcare delivery than physicians, scientists, and other clinical professionals.

Dr. Ellis on Heterogeneity Impacting Biomarker Efficacy

May 9th 2012

Dr. Matthew Ellis, from Siteman Cancer Center, on Heterogeneity Impacting Biomarker Efficacy

Dr. Dreicer on Utilizing New Prostate Cancer Therapies

May 9th 2012

Dr. Robert Dreicer, from the Cleveland Clinic, on Utilizing New Prostate Cancer Therapies

'Episode-Based Payment' Could Rein in US Oncology Drug Costs

May 1st 2012

With the recent consideration of the 2010 Affordable Care Act by the US Supreme Court, the rising costs of healthcare have appeared, once again, on our radar screens.

Pazopanib Receives FDA Approval for Treatment of Soft Tissue Sarcoma

April 27th 2012

The FDA has approved pazopanib for the treatment of patients with advanced soft tissue sarcoma who have previously received chemotherapy.

How Fellows Can Add Value to Their Internal Medicine Residency Program

April 15th 2012

There are many ideas that if followed will not just help you to "do your time" during fellowship, but contribute to the internal medicine residency program.

(Never) A Typical Day in the Life of a Pediatric Hematologist/Oncologist

April 15th 2012

There is no such thing as a typical day. Our days are punctuated by the unexpected and our field is so diverse that we often change what we do over the course of our careers. Time alters us and our field.